Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies

No abstract is available for this paper.

• Publication year

  2005

• Venue

  BJU International

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-410X.2005.05540.xPMID 15877724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Bevacizumab (Avastin)].

  2007cited by this paper
• Prognostic factors in prostate cancer

  2006cited by this paper
• Intraobserver and interobserver reproducibility of WHO and Gleason histologic grading systems in prostatic adenocarcinomas

  2006cited by this paper
• Current practice of Gleason grading among genitourinary pathologists.

  2005cited by this paper
• Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens

  2005cited by this paper
• Gleason grading of prostate cancer. Contemporary approach.

  2005cited by this paper
• Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens

  2005cited by this paper
• Representación del "score" Gleason en la biopsia prostática del "score" Gleason definitivo de la prostatectomía radical

  2004cited by this paper
• [Evidence of the radical prostatectomy Gleason score in the biopsy Gleason score].

  2004cited by this paper
• Dendritic cell–tumor cell hybrid vaccination for metastatic cancer

  2004cited by this paper
• Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.

  2004cited by this paper
• Hematopoetic stem cell transplantation for solid tumors in Europe.

  2004cited by this paper
• Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy.

  2004cited by this paper
• The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy Specimens

  2004cited by this paper
• Bevacizumab for Patients with Metastatic Renal Cancer

  2004cited by this paper
• Cancer Statistics, 2004

  2004cited by this paper
• A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.

  2004cited by this paper
• Preliminary antitumor activity of BAY 43-9006 in metastatic renal cell carcinoma and other advanced refractory solid tumors in a phase II randomized discontinuation trial (RDT).

  2004cited by this paper
• Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.

  2004cited by this paper
• Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma

  2004cited by this paper
• Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.

  2004cited by this paper
• Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

  2004cited by this paper
• Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial.

  2004cited by this paper
• Novel Antiangiogenic Therapies for Renal Cell Cancer

  2004cited by this paper
• Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.

  2004cited by this paper
• A Pilot Study of Antiangiogenic Therapy with Bevacizumab and Thalidomide in Patients with Metastatic Renal Cell Carcinoma

  2004cited by this paper
• Histopathologic confirmation of complete cancer-cell kill in excised specimens after renal cryotherapy.

  2004cited by this paper
• Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.

  2004cited by this paper
• Adverse effects of thalidomide administration in patients with neoplastic diseases.

  2004cited by this paper
• Better survival with interleukin-2-based regimens? Possibly only in highly selected patients.

  2004cited by this paper
• Prostate Needle Biopsy Reporting: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide Treatment of Prostate Cancer Patients?

  2004cited by this paper
• Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications.

  2004cited by this paper
• Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody.

  2004cited by this paper
• Predicting survival of patients with metastatic renal cell carcinoma

  2004cited by this paper
• Thalidomide in cancer medicine.

  2004cited by this paper
• Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.

  2004cited by this paper
• Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.

  2004cited by this paper
• Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

  2004cited by this paper
• Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

  2004cited by this paper
• A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.

  2003cited by this paper
• Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.

  2003cited by this paper
• Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms.

  2003cited by this paper
• Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials

  2003cited by this paper
• Should each core with prostate cancer be assigned a separate gleason score?

  2003cited by this paper
• Allogeneic hematopoetic stem cell transplantation for cytokine refractory renal cell carcinoma.

  2003cited by this paper
• The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers.

  2003cited by this paper
• A Phase II study of irinotecan in patients with advanced renal cell carcinoma

  2003cited by this paper
• Pancreatic Resection for Metastatic Renal Cell Carcinoma: Presentation, Treatment, and Outcome

  2003cited by this paper
• Treatment of Osseous Metastases in Patients With Renal Cell Carcinoma

  2003cited by this paper
• Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

  2003cited by this paper
• Hepatic Resection for Metastatic Renal Tumors: Is It Worthwhile?

  2003cited by this paper
• Novel therapies for renal cell carcinoma – an update

  2003cited by this paper
• Angiogenesis inhibitors in genitourinary cancers.

  2003cited by this paper
• Prognostic factors in prostate cancer.

  2003cited by this paper
• The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy

  2003cited by this paper
• Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

  2003cited by this paper
• Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.

  2003cited by this paper
• Thalidomide therapy for renal cell carcinoma.

  2003cited by this paper
• Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer.

  2003cited by this paper
• Cell-based immune therapy for metastatic renal cancer

  2003cited by this paper
• Management of thalidomide toxicity.

  2003cited by this paper
• [Surgical treatment of pulmonary metastases from renal cancer].

  2003cited by this paper
• Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes

  2003cited by this paper
• Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.

  2003cited by this paper
• Renal cryotherapy: 2003 clinical status

  2003cited by this paper
• Allogeneic stem cell transplantation as immunotherapy for renal cell carcinoma: from immune enhancement to immune replacement.

  2003cited by this paper
• A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell Carcinoma

  2003cited by this paper
• Adverse events during radiofrequency treatment of 582 hepatic tumors.

  2003cited by this paper
• Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute.

  2003cited by this paper
• Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review

  2003cited by this paper
• Low incidence of ipsilateral adrenal involvement and recurrences in patients with renal cell carcinoma undergoing radical nephrectomy: a retrospective analysis of 393 patients.

  2003cited by this paper
• A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma

  2002cited by this paper
• Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma.

  2002cited by this paper
• A Phase II Study of Thalidomide in Advanced Metastatic Renal Cell Carcinoma

  2002cited by this paper
• [Value of metastases surgery in metastatic renal cell carcinoma].

  2002cited by this paper
• Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie.

  2002cited by this paper
• Toxic Epidermal Necrolysis Associated with Interleukin-2

  2002cited by this paper
• [Interleukin-2 and interferon in metastatic kidney cancer. Experience of the French Immunotherapy Group].

  2002cited by this paper
• Phase II trial of thalidomide for patients with advanced renal cell carcinoma.

  2002cited by this paper
• Global increases in kidney cancer incidence, 1973–1992

  2002cited by this paper
• [Ambulatory radiosurgery in cerebral metastatic renal cell carcinoma. 5-year outcome in 58 patients].

  2002cited by this paper
• [Metastatic kidney cancer: new therapeutic approaches].

  2002cited by this paper
• Repeated gamma knife surgery for multiple brain metastases from renal cell carcinoma.

  2002cited by this paper
• The Identification of Renal Cell Carcinoma as a Target for Allogeneic Based Cancer Immunotherapy

  2002cited by this paper
• A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.

  2002cited by this paper
• Cryoablation and liver resection for noncolorectal liver metastases.

  2002cited by this paper
• Percutaneous Radiofrequency Ablation of Nodal Metastases

  2002cited by this paper
• Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.

  2002cited by this paper
• New technologies for ablation of small renal tumors: current status.

  2002cited by this paper
• Therapy of local recurrence of renal cell carcinoma.

  2002cited by this paper
• Long-term results after pulmonary resection of renal cell carcinoma metastases.

  2002cited by this paper
• Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?

  2002cited by this paper
• Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone.

  2002cited by this paper
• Renal cell carcinoma may adapt to and overcome anti‐angiogenic intervention with thalidomide

  2002cited by this paper
• Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma.

  2002cited by this paper
• Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

  2001cited by this paper
• Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

  2001cited by this paper
• Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.

  2001cited by this paper
• Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

  2001cited by this paper
• Analysis of clinicopathologic factors predicting outcome after radical prostatectomy

  2001cited by this paper

• MATCH: Multi-faceted Adaptive Topo-Consistency for Semi-Supervised Histopathology Segmentation

  2025cites this paper
• Correlation of prostate-specific antigen levels with Gleason score and tumor percentage on prostate needle biopsy in prostate cancer

  2024cites this paper
• Predictive model for laser-induced tissue necrosis with immunohistochemistry validation

  2024cites this paper
• Management Decision in Castration-Resistant Prostate Cancer

  2023cites this paper
• Semi-supervised Segmentation of Histopathology Images with Noise-Aware Topological Consistency

  2023cites this paper
• Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer

  2022cites this paper
• Correlation between Body Mass Index and Gleason Score in Men with Prostate Cancer in Southeastern Nigeria

  2021cites this paper
• Semi-supervised training of deep convolutional neural networks with heterogeneous data and few local annotations: An experiment on prostate histopathology image classification

  2021cites this paper
• Study of serum prostate specific antigen levels in patients with prostate lesions

  2021cites this paper
• Infiltration pattern predicts metastasis and progression better than the T-stage and grade in pancreatic neuroendocrine tumors: a proposal for a novel infiltration-based morphologic grading

  2021cites this paper
• An Audit of Surgical Neck Explorations for Penetrating Neck Injuries in Northwestern Nigeria: Experience from a Teaching Hospital

  2021cites this paper
• TA-Net: Topology-Aware Network for Gland Segmentation

  2021cites this paper
• Multi-scale tissue architecture analysis of favorable-risk prostate cancer: Correlation with biochemical recurrence

  2020cites this paper
• An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies.

  2020cites this paper
• Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers

  2019cites this paper
• Diagnostic Value between 1984 and 2018 of Transrectal Biopsy Guided by Ultrasonography after Radical Prostatectomy

  2019cites this paper
• Understanding the gleason grading system and its changes

  2019cites this paper
• Prostate cancer localization based on multiparametric quantification of three-dimensional transrectal contrast-enhanced ultrasound

  2019cites this paper
• Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management

  2019cites this paper
• Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens

  2019cites this paper
• Multiparametric and multidimensional: a three-dimensional and multiparametric approach to ultrasound imaging of prostate cancer

  2019influential citation
• 3-D Multi-parametric Contrast-Enhanced Ultrasound for the Prediction of Prostate Cancer.

  2019cites this paper
• Gene-Based Tests for Screening , Detection , and / or Management of Prostate Cancer Effective : July 1 , 2018

  2018cites this paper
• Machine Learning for the Prediction of Prostate Cancer Biopsy Based on 3D Dynamic Contrast-Enhanced Ultrasound Quantification

  2018cites this paper
• Determination of the cut-off level of apparent diffusion coefficient values in the detection of prostate cancer

  2018cites this paper
• Clinical significance of subtypes of Gleason pattern 4 prostate cancer

  2018cites this paper
• Gene-Based Tests for Screening , Detection , and / or Management of Prostate Cancer Effective : June 1 , 2018

  2018cites this paper
• Gene-Based Tests for Screening , Detection , and / or Management of Prostate Cancer Effective : April 1 , 2018

  2018cites this paper
• Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management Policy

  2018cites this paper
• Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management

  2018cites this paper
• Protein and Genetic Testing for Prostate Cancer

  2018cites this paper
• Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management Policy # 00403

  2017cites this paper
• Medical Policy Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management

  2017cites this paper
• Unusual Presentation of Metastatic Prostate Cancer: A Case Report

  2017cites this paper
• Gene Expression Analysis for Prostate Cancer Management Effective : May 1 , 2017

  2017cites this paper
• Correlation of serum prostate-specific antigen level in various prostate pathology in elderly men

  2017cites this paper
• Optimal preprocessing of serum and urine metabolomic data fusion for staging prostate cancer through design of experiment.

  2017cites this paper
• Clinical, Pathological and Molecular Prognostic Factors in Prostate Cancer Decision-Making Process

  2016cites this paper
• Prostate cancer: from Gleason scoring to prognostic grade grouping

  2016cites this paper
• Gland segmentation from histology images using informative morphological scale space

  2016cites this paper
• BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression

  2016cites this paper
• Contemporary aspects of prostate cancer grading

  2016cites this paper
• Comparison of prostate cancer grades after biopsy and radical prostatectomy

  2016cites this paper
• Interobserver Reproducibility of Percent Gleason Pattern 4 in Prostatic Adenocarcinoma on Prostate Biopsies

  2016cites this paper
• miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma

  2016cites this paper
• Detection of a Tertiary Pattern of Higher Grade in Core Biopsy Tissues of Prostatic Adenocarcinoma– A Case Report

  2016cites this paper
• Association of high-grade prostatic intraepithelial neoplasia ( HGPIN ) in patients of prostate adenocarcinoma

  2016cites this paper
• Spatial Genome Organization and Its Emerging Role as a Potential Diagnosis Tool

  2016influential citation
• Automated prostate tissue referencing for cancer detection and diagnosis

  2016cites this paper
• Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management

  2016cites this paper
• Do prostate cancer nomograms give accurate information when applied to European patients?

  2015cites this paper
• Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.

  2015cites this paper
• Proposal of Gleason-like grading system of canine prostate carcinoma in veterinary pathology practice.

  2015cites this paper
• Histopathological Study of Transrectal Ultrasound Guided Biopsies of Prostate in Patients With Raised Serum Prostate Specific Antigen

  2015cites this paper
• Image analysis of prostate cancer tissue biomarkers

  2015cites this paper
• Study of Histopathological lesions in transrectal ultrasound guided biopsies of prostate in patients with raised serum prostate specific antigen.

  2015cites this paper
• Gene expression analysis for prostate cancer management.

  2015cites this paper
• РАК ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ: ВОЗМОЖНАЯ РОЛЬ ПАПИЛЛОМАВИРУСОВ В ЕГО ВОЗНИКНОВЕНИИ

  2015cites this paper
• Clinicopathological study of prostatic biopsies.

  2014cites this paper
• Histopathological lesions in Transrectal ultrasound guided biopsies of Prostate in patients with raised serum Prostate specific antigen.

  2014cites this paper
• Interobserver variability in the pathological assessment of radical prostatectomy specimens: Findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study

  2014cites this paper
• DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer

  2014cites this paper
• Microarray-based Gene Expression Analysis for Prostate Cancer Management

  2014cites this paper
• The PI3K Signaling Pathway in Head and Neck Squamous Cell Carcinoma

  2014cites this paper
• Concordance between biopsy and radical prostatectomy specimen Gleason score in internal and external pathology facilities.

  2014cites this paper
• Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?

  2014cites this paper
• Gleason Grading of Prostate Tumours with Max-Margin Conditional Random Fields

  2014cites this paper
• Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression.

  2014cites this paper
• SERUM PSA LEVEL AND GLEASON SCORES OF NEEDLE BIOPSY SPECIMENS PREDICT THE POSTOPERATIVE PATHOLOGIC GRADE OF PROSTATE CANCER

  2013cites this paper
• Smaller prostate gland size and older age predict Gleason score upgrading.

  2013cites this paper
• Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link.

  2013cites this paper
• Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy

  2013cites this paper
• Implications of the International Society of Urological Pathology modified Gleason grading system.

  2012cites this paper
• Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

  2012cites this paper
• Integration of Architectural and Cytologic Driven Image Algorithms for Prostate Adenocarcinoma Identification

  2012cites this paper
• Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume.

  2012cites this paper
• Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death

  2012cites this paper
• RETRACTED ARTICLE: Histopathologische Befundberichte von Prostatastanzbiopsien

  2012cites this paper
• The emerging multiple roles of nuclear Akt.

  2012cites this paper
• Prognostic value of nuclear matrix protein expression in localized prostate cancer

  2012cites this paper
• [Accuracy of prostate biopsies to evaluate tumor location in prostate cancer].

  2012influential citation
• Score de Gleason des biopsies prostatiques et celui des pièces de prostatectomies: Quelle corrélation?

  2012cites this paper
• Male Genital Tract

  2012cites this paper
• Fiabilité des biopsies prostatiques pour l’étude de la topographie tumorale dans le cancer de prostate

  2012influential citation
• Indra Jaya

  2012cites this paper
• The Gleason grading system: where are we now?

  2011cites this paper
• A high-throughput active contour scheme for segmentation of histopathological imagery

  2011cites this paper
• [How to select the best candidates for prostate biopsies? The role of traditional tools and contribution of new biomarkers in prostate cancer].

  2011cites this paper
• Supervised Regularized Canonical Correlation Analysis: integrating histologic and proteomic measurements for predicting biochemical recurrence following prostate surgery

  2011cites this paper
• Combining the Tactile Resonance Method and Raman Spectroscopy for Tissue Characterization towards Prostate Cancer Detection

  2011cites this paper
• Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer

  2011cites this paper
• Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience.

  2011influential citation
• HISTOPATHOLOGICAL LESIONS IN TRANSRECTAL ULTRASOUND GUIDED BIOPSIES OF PROSTATE IN PATIENTS WITH RAISED SERUM PROSTATE SPECIFIC ANTIGEN: A PRELIMINARY REPORT

  2011cites this paper
• Optimization of Complex Cancer Morphology Detection Using the SIVQ Pattern Recognition Algorithm

  2011cites this paper
• Silencing p110β prevents rapid depletion of nuclear pAkt.

  2011cites this paper
• Histopathological image classification using salient point patterns

  2011cites this paper
• Chapter 3 – The Pathology of Prostate Cancer

  2010cites this paper
• Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade

  2010cites this paper
• Inherited Susceptibility of Aggressive Prostate Cancer

  2010cites this paper
• Novel localization of low affinity NGF receptor (p75) in the stroma of prostate cancer and possible implication in neoplastic invasion: An immunohistochemical and ultracytochemical study

  2010cites this paper